Acton Pharmaceuticals
Specialty pharmaceutical company that develops and markets products for the treatment of respiratory conditions.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD209m (Public information from Aug 2013)
Marlborough Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $500k | Early VC | |
$15.0m | Series A | ||
| N/A | $14.2m | Series A | |
| N/A | $7.0m | Series B | |
$135m Valuation: $135m | Acquisition | ||
| Total Funding | AUD56.7m | ||